🇺🇸 FDA
Patent

US 10118961

Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 10118961 (Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV) held by CytomX Therapeutics, Inc. expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CytomX Therapeutics, Inc.
Grant date
Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61K47/6845